Health and Fitness Health and Fitness
Thu, May 13, 2010
Wed, May 12, 2010
[ Wed, May 12th 2010 ] - Market Wire
ENVIROTEK Becomes "SUFFER"
Tue, May 11, 2010
Mon, May 10, 2010
Sun, May 9, 2010
Sat, May 8, 2010
Fri, May 7, 2010
Thu, May 6, 2010
Mon, January 11, 2010
Sat, January 9, 2010
Fri, January 8, 2010
Thu, January 7, 2010
Wed, January 6, 2010
Tue, January 5, 2010
Mon, January 4, 2010
[ Mon, Jan 04th 2010 ] - Market Wire
Cordani Becomes CIGNA CEO
Thu, December 31, 2009
[ Thu, Dec 31st 2009 ] - Market Wire
Quit the Board
Wed, December 30, 2009
[ Wed, Dec 30th 2009 ] - Market Wire
Centric Grants Stock Options
Tue, December 29, 2009
Mon, December 28, 2009

DexCom To Present at the JMP Securities Conference


//health-fitness.news-articles.net/content/2010/ .. to-present-at-the-jmp-securities-conference.html
Published in Health and Fitness on Thursday, May 6th 2010 at 19:42 GMT by Market Wire   Print publication without navigation


SAN DIEGO--([ BUSINESS WIRE ])--DexCom, Inc. (NASDAQ:DXCM) today announced that Steven R. Pacelli, Chief Administrative Officer, will present an update on DexCom at the JMP Securities Conference in San Francisco on Monday, May 10, 2010 at 1:00 pm (PDT). The presentation, which will occur live at the Ritz-Carlton Hotel in San Francisco, will be concurrently webcast. The link to the webcast will be available on the DexCom, Inc. website at [ www.dexcom.com ] under the investor relations, events and webcast section, and will be archived for future reference.

About DexCom, Inc.

DexCom, Inc., headquartered in San Diego, California, is developing and marketing continuous glucose monitoring systems for ambulatory use by patients and by healthcare providers in the hospital.

Cautionary Statement Regarding Forward Looking Statements

DexCom is a medical device company with a limited operating history. Successful commercialization of the companya™s products is subject to numerous risks and uncertainties, including a lack of acceptance in the marketplace by physicians and patients, the inability to manufacture products in commercial quantities at an acceptable cost, possible delays in the companya™s development programs, the inability of patients to receive reimbursement from third-party payors and inadequate financial and other resources. Certain of these risks and uncertainties, in addition to other risks, are more fully described in the companya™s annual report on Form 10-Q for the period ending March 31, 2010, as filed with the Securities and Exchange Commission on May 5, 2010.


Publication Contributing Sources